News/ News/ R&D Takeda halts trial of orexin drug in narcolepsy on safety grounds Phil Taylor central nervous system, narcolepsy, NLS Pharmaceutics, Quilience, safety, Takeda 0 Comment Japanese drugmaker Takeda has suspended dosing in phase 2 trials of its orexin agonist TAK-994, saying it had Share X Takeda halts trial of orexin drug in narcolepsy on safety grounds https://pharmaphorum.com/news/takeda-halts-trial-of-orexin-drug-in-narcolepsy-on-safety-grounds/